Questcor says MS drug sales rise in second-quarter

Questcor Pharmaceuticals Inc reported strong second-quarter sales of its flagship multiple sclerosis drug, sending its shares up as much as 17 percent to a life-high.The biopharmaceutical company shipped 4,710 vials of Acthar for the April-June period, a 15 percent rise from the first quarter.ThinkEquity analyst James Molloy said the total numbers were above his estimates of 4,307 vials."Questcor ...

Alcoa Earns 6 Cents In Q2, Excluding Items, Beats Estimate

Alcoa (NYSE: AA) Inc posted a second-quarter loss as a slump in aluminum prices to near two-year lows offset growing demand in the aerospace and automobile markets.Excluding items, however, Alcoa earned $61 million from continuing operations, or 6 cents per share, which beat Wall Street estimates of 5 cents per share. The company's shares rose slightly in after-hours trade.The loss from continuing...